BSD Medical (BSDM) Reports Initiation of a Phase III Study on Pancreatic Cancer Using the BSD-2000 Hyperthermia System in Combination with Chemotherapy 2/9/2010
More...
|
Soft Drink Consumption May Increase Risk Of Pancreatic Cancer, University of Minnesota Study 2/8/2010
More...
|
Health Discovery Corporation (DWCM.OB) Partners with Major New York City Pancreatic Cancer Center to Develop a New Molecular Diagnostic Test for the Early Detection of Pancreatic Cancer 2/5/2010
More...
|
Pfizer Inc. (PFE) (JOBS) Seeks Sutent OK for Pancreatic Cancer 1/25/2010
More...
|
Pfizer Inc. (PFE)'s Kidney Drug Also Slows Pancreatic Cancer 1/22/2010
More...
|
GenVec Inc. (GNVC) Cancer Drug Gets Orphan Status 11/5/2009
More...
|
Abraxis BioScience, Inc. Release: ABRAXANE(R) Receives Orphan Drug Status for the Treatment of Pancreatic Cancer and Stage IIB-IV Melanoma 11/5/2009
More...
|
Possible Origins Of Pancreatic Cancer Revealed by Massachusetts Institute of Technology (MIT) Biologists 11/3/2009
More...
|
Pancreatic Cancer: Discovery Offers Potential New Treatment, Ohio State University Study 11/3/2009
More...
|
NeoPharm (NEOL) Submits Application for a Multicenter, Open-Label, Phase II Study of LE-DT for Locally Advanced or Metastatic Pancreatic Cancer Patients as a Frontline Treatment 10/27/2009
More...
|
Bioengineered Stem Cells for Pancreatic Cancer Treatment, Massachusetts General Hospital Study 10/15/2009
More...
|
Epeius Biotechnologies Corporation: Advanced U.S. Clinical Trial Confirms Single-Agent Efficacy of Rexin-G in Metastatic Pancreas Cancer 10/14/2009
More...
|
Regeneron Pharmaceuticals, Inc. (REGN) (JOBS), Sanofi-Aventis (France) (SASY.PA) Drug Fails Against Pancreatic Cancer 9/15/2009
More...
|
Eurand Granted FDA Approval for ZENPEP(TM) 8/28/2009
More...
|
New Tool May Help With Early Detection Of Deadly Pancreatic Cancer, Van Andel Institute Study 8/5/2009
More...
|
Risk of Pancreatic Cancer Linked to Variation in Gene that Determines Blood Type 8/4/2009
More...
|
Calypso Medical Technologies Study Shows Potential for Improving Radiotherapy Treatment Accuracy of Deadly Pancreatic Tumors 7/27/2009
More...
|
New Drug Candidate Prolongs the Lives of Pancreatic Cancer Patients, Tel Aviv University Study 7/22/2009
More...
|
Pfizer Inc. (PFE)'s (JOBS) Sutent Effective vs Rare Pancreatic Cancer 6/26/2009
More...
|
FDA Extends Review Period for Eurand's ZENPEP(TM) Pancreatic Enzyme Replacement Therapy 6/22/2009
More...
|
Epeius Biotechnologies Corporation's Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer 6/17/2009
More...
|
New Pathology Tests Double Sensitivity To Detect Bile Duct And Pancreatic Cancers, Mayo Clinic Study 6/3/2009
More...
|
Novel Targeted Radiation Therapy From Immunomedics, Inc. (IMMU) Produces Objective Responses in Pancreatic Cancer 6/1/2009
More...
|
New Paper in Science Features Infinity Pharmaceuticals, Inc.'s IPI-926 Hedgehog Pathway Inhibitor as a Promising New Approach in Chemo-Resistant Pancreatic Cancer 5/29/2009
More...
|
Study Shows Pancreatic Cancer Drug May Fail; Cancer Treatments Such As Eli Lilly and Company (LLY)ss Gemzar Were Often Ineffective 5/22/2009
More...
|
Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer, University of California, Los Angeles (UCLA) Study Suggests 5/1/2009
More...
|
Charred Meat May Increase Risk Of Pancreatic Cancer, University of Minnesota Study 4/22/2009
More...
|
Herbal Extract Inhibits Development Of Pancreatic Cancer, Kimmel Cancer Institute Study 4/21/2009
More...
|
New Drug Achieves Pancreatic Cancer Tumor Remission And Prevents Recurrence, Sidney Kimmel Cancer Center Study 4/20/2009
More...
|
Immutep S.A. Announces Start of Clinical Trial in Pancreatic Cancer 4/15/2009
More...
|
Strategic Approach To Early-Detection Of Pancreatic Cancer Biomarkers, Johns Hopkins University School of Medicine Study 4/8/2009
More...
|
Rexahn Pharmaceuticals, Inc. Initiates Phase II Pancreatic Cancer Clinical Trial 3/24/2009
More...
|
Marshall Edwards, Inc. (NVGN): Triphendiol Safety Data Clears the Way for Compound to Be Studied Further in the Treatment of Pancreatic Cancer 3/18/2009
More...
|
Blood Type, Pancreatic Cancer Risk Linked, Dana-Farber Cancer Institute Study 3/11/2009
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Completes Enrollment Ahead of Schedule in Phase 2 Trial for RP101 in Late-Stage Pancreatic Cancer Patients 3/9/2009
More...
|
Gene Involved In Pancreatic Cancer Identified, University of Michigan Study 3/4/2009
More...
|
University of Michigan Researchers ID Gene Involved in Pancreatic Cancer 3/3/2009
More...
|
Experimental Technique Safely Differentiates Patients With Pancreatic Cancer, Precursor Lesions And Benign Tumors, Northwestern University Study 2/25/2009
More...
|
Immunomedics, Inc. (IMMU)' hPAM4 Labeled With Yttrium-90 Receives Fast Track Designation From FDA for Therapy of Pancreatic Cancer 2/5/2009
More...
|
Pfizer Inc. (PFE) (JOBS) Pancreatic Cancer Drug Fails, Trial Halted 2/2/2009
More...
|
USA FDA Allows BioCancell Therapeutics to Commence Phase I/IIa Ovarian and Pancreatic Clinical Trials 1/14/2009
More...
|
Immunomedics, Inc. (IMMU)' hPAM4 Labeled With Yttrium-90 Receives Orphan Medicinal Product Designation in Europe for Therapy of Pancreatic Cancer 12/19/2008
More...
|
FibroGen, Inc. Has Commenced an Open-Label, Phase 1 Clinical Trial of FG-3019, Anti-Connective Tissue Growth Factor (CTGF) Investigational Therapy, in Patients With Pancreatic Cancer 12/16/2008
More...
|
Radiation Before Surgery Improves Pancreatic Cancer Outcomes, NewYork-Presbyterian Hospital/Weill Cornell Medical Center Study Shows 12/15/2008
More...
|
Enzyme May Hold Key To Successfully Treating Pancreatic Cancer With Targeted Immunotherapy, Thomas Jefferson University Study 12/10/2008
More...
|
PharmaEngine, Inc. Receives Approval of US IND Application for a Phase II Study of PEP02 (Liposome Irinotecan Injection) in Pancreatic Cancer 12/3/2008
More...
|
Marshall Edwards, Inc. (NVGN) Files IND Application for Triphendiol 12/1/2008
More...
|
GenVec Inc. (GNVC) Announces Interim Survival Data in Pivotal Trial of TNFerade(TM) in Locally Advanced Pancreatic Cancer 11/19/2008
More...
|
GenVec Inc. (GNVC)'s TNFerade(TM) Receives FDA Fast Track Designation for Treatment of Pancreatic Cancer 11/11/2008
More...
|
University of California, Davis (UCD) Researchers Discover Achilles' Heel In Pancreatic Cancer 11/7/2008
More...
|
Epeius Biotechnologies Corporation Release: Rexin-G Returns to The Big Apple: Clinical Trials for Pancreatic Cancer and Breast Cancer Open in Manhattan 10/30/2008
More...
|
Infinity Pharmaceuticals, Inc.'s Hedgehog Pathway Inhibitor IPI-926 Demonstrates Significant Tumor Growth Inhibition in Human Pancreatic Cancer Model 10/24/2008
More...
|
MediGene AG (DX:MDG) Reports Positive Final Results from EndoTAG(TM)-1 Phase II Study in Pancreatic Cancer 10/20/2008
More...
|
FDA Grants Orphan Drug Status to Reata Pharmaceuticals, Inc.’s RTA 402 for Treatment of Pancreatic Cancer 10/15/2008
More...
|
Scientists At Jefferson Medical College And Kimmel Cancer Center Deliver Toxic Genes To Effectively Kill Pancreatic Cancer Cells 9/25/2008
More...
|
Radiosurgery Proves Viable For Some Pancreatic Cancers, Georgetown University's Lombardi Comprehensive Cancer Center Study 9/23/2008
More...
|
MediGene, Inc. Drug Extends Pancreatic Cancer Survival 9/16/2008
More...
|
Comprehensive Genetic Blueprints Revealed For Lethal Pancreatic, Brain Cancers, Johns Hopkins Kimmel Cancer Center Study 9/5/2008
More...
|
New Gene Therapy Kills Pancreatic Cancer Cells, Virginia Commonwealth University Study 8/6/2008
More...
|
pSivida Limited (PSD.AX): BrachySil™ Phase IIb Pancreatic Cancer Trials Commence 7/7/2008
More...
|
Results from ValiRx Plc in the Epigenetics Field 6/26/2008
More...
|
Immunomedics, Inc. (IMMU) Announces Fractionated Pretargeted Radioimmunotherapy Improves Pancreatic Cancer Therapy in Animal Model 6/18/2008
More...
|
Biomarkers of Early-Stage Pancreatic Cancer in Mice and Man Identified in Fred Hutchinson Cancer Research Center, Massachusetts General Hospital, University of Michigan, and Dana-Farber Cancer Institute Collaborative Study 6/12/2008
More...
|
New Treatment Combination Safe For Pancreatic Cancer Patients, University of Pittsburgh Study Finds 6/6/2008
More...
|
ANTISENSE PHARMA GmbH Release: Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 6/3/2008
More...
|
Data from Clinical Trial of MediGene AG (DX:MDG)'s EndoTAGTM-1 in the Indication Pancreatic Cancer will be presented at American Society of Clinical Oncology Annual Meeting 5/30/2008
More...
|
New Discovery At Oregon Health & Science University (OHSU) May Lead To Early Cancer Detection 5/23/2008
More...
|
ImClone Systems Incorporated (IMCL) Release: Phase I/II Studies of IMC-A12 in Pancreatic Cancer Open for Patient Enrollment 5/20/2008
More...
|
Traditional Herbal Medicine Kills Pancreatic Cancer Cells, Thomas Jefferson University Researchers Report 5/19/2008
More...
|
Epeius Biotechnologies Corporation Tumor-Targeted Rexin-G Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Metastatic Pancreatic Cancer 5/19/2008
More...
|
Pharmexa A/S (PHARMX.CO) Stops One of Two Phase III Trials 5/13/2008
More...
|
AmpliMed Corporation Announces Start of Randomized Phase 2 Trial of Amplimexon in Pancreatic Cancer 5/1/2008
More...
|
BSD Medical (BSDM) Release: Multiple Studies Demonstrate the Use of Hyperthermia Therapy in Treating Pancreatic Cancer 4/24/2008
More...
|
Epeius Biotechnologies Corporation Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer Second Phase Opens With Higher Dose Regimens 4/21/2008
More...
|
ProMetic Life Sciences Inc. (PFSCF.PK) Presents Preclinical Data for Prostate and Pancreatic Cancer 4/17/2008
More...
|
ProMetic Life Sciences Inc. (PFSCF.PK) Presents Preclinical Data for Prostate and Pancreatic Cancer at the American Association for Cancer Research Meeting 4/17/2008
More...
|
Morphotek Inc. Receives European Orphan Status 4/16/2008
More...
|
Blood Pressure Drugs Halt Pancreatic Cancer Cell Growth, Thomas Jefferson University Researchers Find 4/15/2008
More...
|
Red Wine Compound May Kill Pancreatic Cancer Cells, University of Rochester Study 4/15/2008
More...
|
Oncothyreon's PX-478 Enhances Antitumor Effects of Radiation Therapy in Preclinical Models of Pancreatic and Brain Cancer 4/15/2008
More...
|
Senesco Technologies, Inc. (SNT) Expands on Recently Announced Preclinical Pancreatic Islet Data 4/15/2008
More...
|
GenVec Inc. (GNVC) Presents New Research on TNFerade(TM) 4/15/2008
More...
|
MediGene AG (DX:MDG) Presents Details of the Excellent Clinical Efficacy Data Obtained with EndoTAG(TM)-1 in the Indication Pancreatic Carcinoma 4/7/2008
More...
|
Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project 3/27/2008
More...
|
Marshall Edwards, Inc. (NVGN)'s Compound Triphendiol May Aid in Treatment of Pancreatic Cancer 3/25/2008
More...
|
Finnish Researchers Found Flavonoids Reduce Pancreatic Cancer Risk Among Male Smokers 3/21/2008
More...
|
Immunomedics, Inc. (IMMU) Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers 3/20/2008
More...
|
MediGene AG (DX:MDG) Achieves Excellent Efficacy Data of EndoTAG(TM)-1 in Clinical Phase II Trial in Pancreatic Carcinoma 3/17/2008
More...
|
Raven Biotechnologies, Inc. Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer 3/13/2008
More...
|
Gemcitabine Not a Clear Winner for Adjuvant Treatment of Pancreatic Cancer, University of Maryland Study 3/5/2008
More...
|
Mesothelin Engineered On Virus-like Particles Provides Treatment Clues For Pancreatic Cancer, Baylor College of Medicine Study 2/19/2008
More...
|
Avantogen Oncology, Inc. Release: Phase 2 Trial of RP101 in Late-Stage Pancreatic Cancer Patients Initiated by SciClone Pharmaceuticals, Inc. (SCLN) 2/7/2008
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Initiates Phase 2 Trial of RP101 in Late-Stage Pancreatic Cancer Patients 2/4/2008
More...
|
MethylGene Reports MGCD0103 Clinical Data at the 2008 Gastrointestinal Cancers Symposium 1/28/2008
More...
|
pSivida Limited (PSD.AX)'s BrachySil(TM) in Pancreatic Cancer Study Results to be presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium 1/23/2008
More...
|
Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer 1/23/2008
More...
|
Orphan Drug Status Granted for Marshall Edwards, Inc. (NVGN)' Investigational Anti-Cancer Drug Triphendiol (NV-196) 1/22/2008
More...
|
Thomas Jefferson University Scientists Find Protein Helps Pancreatic Cancer Cells Hide from Immune System, Allowing Spread 1/15/2008
More...
|
Morphotek Inc. Announces Initiation of MORAb-009 Phase II Study in First Line Treatment of Pancreatic Cancer 1/7/2008
More...
|
GenVec Inc. (GNVC) Announces Protocol Changes for PACT Study After Discussions with FDA 1/3/2008
More...
|
Zinc Transporters Regulate Pancreatic Cancer, Baylor College of Medicine Study 11/13/2007
More...
|
Roche (RHHBY) Avastin Misses Endpoint in Pancreatic Cancer Study 11/13/2007
More...
|
Apples Reduce Pancreatic Cancer Risk 10/5/2007
More...
|
Tapestry Pharmaceuticals, Inc. (TPPH) Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer 10/3/2007
More...
|
Chemotherapy with Gemcitabine Delays Progression of Operable Pancreatic Cancer 9/27/2007
More...
|
Novacea, Inc. (NOVC) Initiates Phase 2 Trial of Asentar in Advanced Pancreatic Cancer 9/26/2007
More...
|
University of Georgia Researchers Set Sights on Early Detection of Pancreatic Cancer 8/23/2007
More...
|
YM BioSciences (YM.TO)', European Partner, Oncoscience AG, Announces Initiation Of Advanced Nimotuzumab Trials In Adult Glioma And Pancreatic Cancer 8/21/2007
More...
|
Birth Records Hold Pancreatic Cancer Clue 8/16/2007
More...
|
pSivida Limited (PSD.AX) Completes Recruitment of European Pancreatic Cancer Study and Releases Preliminary Findings 8/13/2007
More...
|
Response Genetics, Inc. Study to Focus on Developing Diagnostic Test Kits for Pancreatic Cancer 8/7/2007
More...
|
Shining Light on Pancreatic Cancer 8/1/2007
More...
|
Method Shows Promise for Early Detection of Pancreatic Cancer 8/1/2007
More...
|
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial, University of Texas M. D. Anderson Cancer Center Study 7/10/2007
More...
|
Epeius Biotechnologies Corporation Takes Aim at Pancreatic Cancer With an Advanced Phase I/II Clinical Trial Using Rexin-G(TM), a Targeted Injectable Gene Delivery System 7/10/2007
More...
|
Cell Receptor May Lead to New 'Biomarker' for Pancreatic Cancer, University of Cincinnati Study 7/2/2007
More...
|
Neogenix Oncology, Inc. Selects Goodwin Biotechnology, Inc. for Manufacturing of its Monoclonal Antibody 6/26/2007
More...
|
Trial Supports Use of Marker to Predict How Pancreatic Cancer Patients Do After Surgery, Thomas Jefferson University Surgeon Finds 6/25/2007
More...
|
Pfizer Inc. (PFE) to Advance Three Key Oncology Compounds into Phase 3 Trials in 2007, Company Tells Financial Analysts 6/5/2007
More...
|
Immunomedics, Inc. (IMMU) Reports Initial Clinical Results With Hpam4 For Pancreatic Cancer Therapy 6/5/2007
More...
|
New Data Show Pfizer Inc. (PFE)'s (Jobs) Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy 6/4/2007
More...
|
Cell Genesys, Inc. (CEGE) Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 6/4/2007
More...
|
GenVec Inc. (GNVC) Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade(TM) at American Society of Clinical Oncology 6/4/2007
More...
|
Study Finds That Dietary Vitamin B6, B12 and Folate, May Decrease Pancreatic Cancer Risk Among Lean People 6/1/2007
More...
|
Cytogen Corporation (CYTO) Reports Publication Validating the Utility of its Proprietary ProChart(TM) Database 5/23/2007
More...
|
Repligen Corporation (RGEN) (Jobs) Reports Positive Phase 2 Clinical Trial Results of Secretin for MRI Imaging of the Pancreas 5/10/2007
More...
|
SciClone Pharmaceuticals, Inc. (SCLN) Acquires Clinical-Stage Pancreatic Cancer Compound 4/26/2007
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces Pivotal Phase III Tarceva(R) Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer 4/25/2007
More...
|
Pancreatic Cancer Vaccine Halts Progression of Disease in Some Patients, University of Pittsburgh Study Finds 4/18/2007
More...
|
Indian Herbal Remedy Cancer Hope, University of Pittsburgh's Study Shows 4/18/2007
More...
|
Thallion Pharmaceuticals Inc. Presents Data at the 2007 Annual Meeting of the American Association for Cancer Research on its Oncology Drug Candidates ECO-4601 and CAP-232 4/18/2007
More...
|
GenVec Inc. (GNVC) Announces New Research at American Association for Cancer Research on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy 4/17/2007
More...
|
Early Stage Pancreatic Cancer Expresses Antigen Targeted by Immunomedics, Inc. (IMMU)'s PAM4 Antibody 4/17/2007
More...
|
ImClone Systems Incorporated (IMCL) and Bristol-Myers Squibb Company (BMY) Data Available from ERBITUX(R) Phase III Study; Drug Fails to Extend Life in Pancreatic Cancer 4/10/2007
More...
|
Swiss Reject Roche Holding AG (RHHBF.PK)'s Tarceva for Pancreatic Cancer 3/29/2007
More...
|
Protein Found to Shield Pancreatic Cancer Cells from Self-Destruction: University of Texas M. D. Anderson Cancer Center Study 3/20/2007
More...
|
British Doctors Will Start New Phase III Trial with Pharmexa Inc.'s GV1001 Vaccine 3/15/2007
More...
|
Gene Discovery by Fred Hutchinson Cancer Research Center Researchers Sheds Light on Pancreatic Cancer 3/13/2007
More...
|
Threshold Pharmaceuticals, Inc. (THLD) (Jobs) Announces Phase 3 Clinical Trial of Glufosfamide for Treatment of Pancreatic Cancer Did Not Meet Its Primary Endpoint 2/27/2007
More...
|
First Evidence Of Stem Cells In Pancreatic Tumors 2/13/2007
More...
|
Scientists Identify Pancreatic Cancer Stem Cells 2/1/2007
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces European Regulatory Approval Of Tarceva(R) For Treatment Of Patients With Pancreatic Cancer 1/29/2007
More...
|
Avastin Fails Trials For Pancreatic Cancer 1/24/2007
More...
|
Pancreatic Cancer Vaccine May Help Some Patients 1/22/2007
More...
|
Cell Genesys, Inc. (CEGE) Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial Of GVAX(R) Immunotherapy For Pancreatic Cancer 1/22/2007
More...
|
BTG plc (BGC.L)'s Plevitrexed Shows Promising Efficacy And Tolerability In A Phase I/II Study 1/22/2007
More...
|
The Day In Review: Gemzar From Eli Lilly and Company (LLY) Effective For Pancreatic Cancer 1/18/2007
More...
|
Eli Lilly and Company (LLY) Gemzar Could Have New Use; Chemotherapy Drug May Halt Return Of Pancreatic Cancer 1/17/2007
More...
|
Gum Disease Linked With Pancreatic Cancer In Study 1/17/2007
More...
|
Gemcitabine May Delay Pancreatic Cancer Return 1/17/2007
More...
|
Point Therapeutics (POTP) Provides Preliminary Results From Phase 2 Metastatic Pancreatic Cancer Study; Cancer Drug Improves Survival Chances 1/12/2007
More...
|
Micro Molecules Can Identify Pancreatic Cancer 1/11/2007
More...
|
GenVec Inc. (GNVC) Receives Clearance From FDA For EUS Administration Of TNFerade(TM) 1/11/2007
More...
|
Oncolytics Biotech Inc. (ONC.TO) Announces Approval For U.K. Clinical Trial Investigating REOLYSIN(R) In Combination With Gemcitabine 1/3/2007
More...
|
Phase II Clinical Trial Of Biomira Inc. (BIOM)'s PX-12 In Patients With Advanced Pancreatic Cancer Now Open For Patient Enrollment 1/2/2007
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Top-Line Phase 2 Clinical Trial Results Of Glufosfamide For Treatment Of Pancreatic Cancer; Stocks Rise 12/28/2006
More...
|
Key To Why Pancreatic Cancer Kills So Often 12/26/2006
More...
|
'Dua Anti-reflux Valve' Found To Improve Quality Of Life For Bile Duct-Pancreatic Cancer Patients 12/21/2006
More...
|
Allergy Drug Slows Pancreatic Tumor Growth In Preclinical Studies 12/20/2006
More...
|
GenVec Inc. (GNVC) Announces Efficacy Update In Phase II/III Clinical Trial Of TNFerade(TM) In Locally Advanced Pancreatic Cancer; Initial Data Positive 12/19/2006
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces That Tarceva(R) Received Positive Opinion From Health Authorities In European Union For The Treatment Of Patients With Pancreatic Cancer 12/15/2006
More...
|
GenVec Inc. (GNVC) Announces Completion Of Interim Safety Data Analysis For Phase II/III Trial With TNFerade(TM) In Pancreatic Cancer 12/14/2006
More...
|
First Familial Pancreatic Cancer Gene Identified 12/12/2006
More...
|
'Dua Anti-reflux Valve' Found To Improve Quality Of Life For Bile Duct/Pancreatic Cancer Patients 12/12/2006
More...
|
Philadelphia Group Confirms GenoMed, Inc.'s Approach To Pancreatic Cancer 12/12/2006
More...
|
Blood Pressure Drugs Could Help Halt Pancreatic Cancer Spread, Thomas Jefferson University Researchers Find 12/8/2006
More...
|
Sugar-Packed Diet May Boost Pancreatic Cancer Risk 11/30/2006
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Announces Change In Guidance For Release Of Phase 3 Trial Results In Pancreatic Cancer; Results Delayed 11/29/2006
More...
|
The Day In Review: Dynavax Technologies Corporation (DVAX) Reports Heplisav Success Against Hepatitis B 11/29/2006
More...
|
Fizzy Drinks Increase Risk Of Pancreatic Cancer 11/8/2006
More...
|
ImmunoGen, Inc. (IMGN) Announces Presentation Of HuC242-DM4 Clinical Data At EORTC-NCI-AACR Conference 11/8/2006
More...
|
Morphotek Inc. Release: Monoclonal Antibody, MORAb-009, Receives FDA Orphan Drug Designation For The Indication Of Pancreatic Cancer 11/7/2006
More...
|
Avantogen Oncology, Inc. Announces FDA Acceptance Of Its IND For The Novel Cancer Drug Candidate, RP101 10/31/2006
More...
|
MethylGene Initiates Phase I/II Combination Clinical Trial With Its Proprietary HDAC Inhibitor, MGCD0103, And Gemzar'R' In Patients With Pancreatic Cancer 10/26/2006
More...
|
Pharmion Corporation (PHRM) Initiates Phase One/Two Combination Clinical Trial With MGCD0103 And Gemzar(R) In Patients With Pancreatic Cancer 10/26/2006
More...
|
Myriad Genetics, Inc. (MYGN) Sponsors Clinical Trial In Pancreatic Cancer 10/24/2006
More...
|
First Patient Implanted In pSivida Limited (PSD.AX) European Pancreatic Cancer Study 10/9/2006
More...
|
Epeius Biotechnologies Corporation Gains Federal Support For Landmark Clinical Trials Of Tumor-Targeted Gene Therapy Using Rexin-G(TM) For Metastatic Cancer 10/2/2006
More...
|
Avantogen Oncology, Inc. Files IND Application For RP101 10/2/2006
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Receives Orphan Drug Designation For Glufosfamide 9/28/2006
More...
|
Ecopia BioSciences Inc. (EIA.TO) To Include Pancreatic Cancer Patients In Its Ongoing Phase I Clinical Trial 9/19/2006
More...
|
SR Pharma PLC (SPA.L) Gets Encouraging Results In Mice For Pancreatic Cancer Drug 9/14/2006
More...
|
Vitamin D May Cut Pancreatic Cancer Risk By Nearly Half 9/12/2006
More...
|
Gloucester Pharmaceuticals, Inc. Initiates Phase I/II Clinical Study In Pancreatic And Other Advanced Solid Tumors; Combination Trial Will Investigate Romidepsin (Depsipeptide) In Combination With Gemcitabine 9/12/2006
More...
|
Roche (RHHBY) Requests Re-Examination Of CHMP Opinion On Tarceva In Pancreatic Cancer At The European Medicines Agency 9/5/2006
More...
|
Avantogen Oncology, Inc. Announces Preliminary Results Of A Dose Ranging Study Of RP101 In Combination With Gemcitabine Chemotherapy In Patients With Advanced Pancreatic Cancer 8/17/2006
More...
|
Epeius Biotechnologies Corporation Receives Accelerated Approval For Rexin-G(TM) In The Philippines 8/10/2006
More...
|
Threshold Pharmaceuticals, Inc. (THLD) Completes Enrollment In Phase 3 And Phase 2 Trials For The Treatment Of Pancreatic Cancer 8/9/2006
More...
|
OSI Pharmaceuticals, Inc. (OSIP) Announces That Roche (RHHBY) Has Received Negative CHMP Opinion In European Union On Tarceva(R) In Pancreatic Cancer 7/28/2006
More...
|
Cambridge Antibody Technology Group PLC (CATG) Announces Acquisition of Oncology Product Candidate From Enzon Pharmaceuticals, Inc. (ENZN) 7/27/2006
More...
|
Chilli Could Boost Insulin Control, Says Study 7/24/2006
More...
|
BSD Medical (BSDM)'s BSD-2000 May Provide Hope For Pancreatic Cancer Patients 7/19/2006
More...
|
Proteins Linked To Pancreatic Cancer Spread Found 7/18/2006
More...
|
Intraop Medical, Inc. Release: IOERT Shown To Be Effective In Treating Pancreatic Cancer 7/12/2006
More...
|
Genentech, Inc. (DNA) Release: Phase III Study Of Avastin(R) In Advanced Pancreatic Cancer Does Not Meet Primary Endpoint; Company Halts Study 6/27/2006
More...
|
Red Meat Associated With Pancreatic Cancer 6/27/2006
More...
|
ArQule, Inc. (ARQL) Initiates Phase 2 Clinical Development Of ARQ 501 For Pancreatic Cancer 6/20/2006
More...
|
Epeius Biotechnologies Corporation Receives $400,000 Grant To Support Gene Therapy Trials For Pancreatic Cancer 6/19/2006
More...
|
Aida Pharmaceuticals, Inc. (AIDA) Expands Pharmaceutical Pipeline With Three New Drugs 6/13/2006
More...
|
Avantogen Limited And Innovate Oncology, Inc. Announce ASCO Abstracts Highlighting The Progress In The Evaluation Of RP101 In Combination With Chemotherapy For Patients With Pancreatic Cancer 6/9/2006
More...
|